Pharmaceutiques - Article on EG110A

Pharmaceutiques dated January 2024 (n°314) talks about EG110A clinical development plans for this year, and the great need for innovations to improve patient's care in Neurogenic bladder and Overactive bladder.


Essential Cookies

These cookies are necessary for the website to function and cannot be turned off. They are used, for example, to maintain the contents of the user's basket. You can set your browser to block these cookies, but then the website will not function prope

Always active

Analytical cookies

These cookies allow you to count visits and traffic sources. Thanks to these files, it is known which pages are more popular and how the website visitors navigate. All information these cookies collect is anonymous.